In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1988-03

AUTHORS

G J Peters, J van Dijk, E Laurensse, C J van Groeningen, J Lankelma, A Leyva, J C Nadal, H M Pinedo

ABSTRACT

The effect of delayed uridine administration on the in vitro growth inhibitory effects of 5-fluorouracil (5FU) and on the in vivo antitumour activity and toxicity was studied. In vitro growth inhibition of the human intestinal cell lines WiDr and Intestine 407 by 3 microM 5FU could be reversed by 1.0 mM uridine; the effect was more pronounced with WiDr cells. At 0.1 mM uridine an intermediate effect was observed. Inhibition of colony formation in both cell lines could also be reversed by delayed administration of uridine at 0.1 and 1 mM. Incorporation of 5FU into RNA of WiDr cells did not proceed after addition of uridine, in contrast to Intestine 407 cells. In these cells only a partial inhibition was observed. In vivo we studied the effect of uridine on two colon carcinoma tumour lines, the 5FU sensitive Colon 38 and the relatively resistant Colon 26. 5FU was administered i.p. in a weekly schedule. With Colon 26 delayed administration of uridine (3500 mg kg-1) at 2 and 20 h after 5FU enabled us to increase the 5FU dose from 100 to 250 300mg kg-1. The combination of high-dose 5FU and uridine resulted both in a superior antitumour effect and an increase in life span. In the 5FU sensitive Colon 38 we determined whether the sensitivity to 5FU was affected by uridine. Mice were treated at the non-lethal dose of 100 mg kg-1 which inhibited tumour growth almost completely. Delayed administration of uridine did not significantly affect the antitumour effect. In non-tumour bearing mice we studied the time course of the reversal of the haematological toxicity of 5FU. The effective dose of 100 mg kg-1 induced a significant decrease in leukocytes; in combination with delayed uridine the leukopenia was less severe and recovered more rapidly. 5FU also induced a decrease in haematocrit, which could be prevented by delayed administration of uridine. In conclusion, in cell culture the reversal of 5FU cytotoxicity could be achieved at a low concentration of 0.1 mM uridine, the extent of the reversal might be related to the 5FU incorporation into RNA. In vivo the relatively resistant tumour Colon 26 could be treated with a higher dose of 5FU in the presence of uridine. The sensitivity to 5FU of the sensitive Colon 38 was not affected by delayed administration of uridine, while the haematological toxicity of 5FU was less. So, delayed administration of uridine after 5FU resulted in an improved therapeutic effect in both a relatively resistant and sensitive tumour. More... »

PAGES

259

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1988.56

DOI

http://dx.doi.org/10.1038/bjc.1988.56

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044394514

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3355763


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colonic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intestinal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred C57BL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uridine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Oncology, Free University Hospital, Amsterdam, The Netherlands."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peters", 
        "givenName": "G J", 
        "id": "sg:person.01255301342.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255301342.17"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "van Dijk", 
        "givenName": "J", 
        "id": "sg:person.0717716531.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717716531.20"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Laurensse", 
        "givenName": "E", 
        "id": "sg:person.01217753643.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217753643.01"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "van Groeningen", 
        "givenName": "C J", 
        "id": "sg:person.01072777672.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072777672.33"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Lankelma", 
        "givenName": "J", 
        "id": "sg:person.0655351752.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655351752.04"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Leyva", 
        "givenName": "A", 
        "id": "sg:person.01222564175.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222564175.18"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Nadal", 
        "givenName": "J C", 
        "id": "sg:person.01031265312.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031265312.27"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Pinedo", 
        "givenName": "H M", 
        "id": "sg:person.013437631522.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013437631522.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/1097-0142(197711)40:5+<2660::aid-cncr2820400940>3.0.co;2-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012307934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00256691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021909500", 
          "https://doi.org/10.1007/bf00256691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00256691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021909500", 
          "https://doi.org/10.1007/bf00256691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.2042-7158.1986.tb04552.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028831366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00292865", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035577687", 
          "https://doi.org/10.1007/bf00292865"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(87)90053-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036522081"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00253962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046577841", 
          "https://doi.org/10.1007/bf00253962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00253962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046577841", 
          "https://doi.org/10.1007/bf00253962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1016410817898", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049087466", 
          "https://doi.org/10.1023/a:1016410817898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076981818", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078803298", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079490924", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079799337", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079909315", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079921497", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081549835", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081679216", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081779465", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081888390", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081992384", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082152911", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082240687", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1988-03", 
    "datePublishedReg": "1988-03-01", 
    "description": "The effect of delayed uridine administration on the in vitro growth inhibitory effects of 5-fluorouracil (5FU) and on the in vivo antitumour activity and toxicity was studied. In vitro growth inhibition of the human intestinal cell lines WiDr and Intestine 407 by 3 microM 5FU could be reversed by 1.0 mM uridine; the effect was more pronounced with WiDr cells. At 0.1 mM uridine an intermediate effect was observed. Inhibition of colony formation in both cell lines could also be reversed by delayed administration of uridine at 0.1 and 1 mM. Incorporation of 5FU into RNA of WiDr cells did not proceed after addition of uridine, in contrast to Intestine 407 cells. In these cells only a partial inhibition was observed. In vivo we studied the effect of uridine on two colon carcinoma tumour lines, the 5FU sensitive Colon 38 and the relatively resistant Colon 26. 5FU was administered i.p. in a weekly schedule. With Colon 26 delayed administration of uridine (3500 mg kg-1) at 2 and 20 h after 5FU enabled us to increase the 5FU dose from 100 to 250 300mg kg-1. The combination of high-dose 5FU and uridine resulted both in a superior antitumour effect and an increase in life span. In the 5FU sensitive Colon 38 we determined whether the sensitivity to 5FU was affected by uridine. Mice were treated at the non-lethal dose of 100 mg kg-1 which inhibited tumour growth almost completely. Delayed administration of uridine did not significantly affect the antitumour effect. In non-tumour bearing mice we studied the time course of the reversal of the haematological toxicity of 5FU. The effective dose of 100 mg kg-1 induced a significant decrease in leukocytes; in combination with delayed uridine the leukopenia was less severe and recovered more rapidly. 5FU also induced a decrease in haematocrit, which could be prevented by delayed administration of uridine. In conclusion, in cell culture the reversal of 5FU cytotoxicity could be achieved at a low concentration of 0.1 mM uridine, the extent of the reversal might be related to the 5FU incorporation into RNA. In vivo the relatively resistant tumour Colon 26 could be treated with a higher dose of 5FU in the presence of uridine. The sensitivity to 5FU of the sensitive Colon 38 was not affected by delayed administration of uridine, while the haematological toxicity of 5FU was less. So, delayed administration of uridine after 5FU resulted in an improved therapeutic effect in both a relatively resistant and sensitive tumour.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.1988.56", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "57"
      }
    ], 
    "name": "In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil", 
    "pagination": "259", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d377dd4f8106121fea2102b662251d3f8d39f6ab492bafcdec81e95ffb541213"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3355763"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1988.56"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044394514"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1988.56", 
      "https://app.dimensions.ai/details/publication/pub.1044394514"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_53990_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc198856"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1988.56'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1988.56'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1988.56'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1988.56'


 

This table displays all metadata directly associated to this object as RDF triples.

214 TRIPLES      21 PREDICATES      62 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1988.56 schema:about N0b32b25d25f946ba875f3502bf0d71d9
2 N10d2fdb3a6364e33b44dfd0b5d738df5
3 N2a914b0340514f6ea8dd1b57c24263f2
4 N3d2f34173cb54825aef2c5667559637b
5 N476fd41702144691b942da7058b8a729
6 N4811b0c0632d409f95ae6b57dd297341
7 N57e8516c7fdc488e9bb611fad2c28b00
8 N6ac99fe6f29d41aa84a867e3b9401016
9 N81366d96ea184bc4971675edd27b7969
10 N8ea1d51762fe4034a643dbd868a66152
11 Naca72129c7d5481b97ceaeafa5b1039f
12 Nbbe5161fbcfb4525b2b5b270f9dce0a2
13 Nf98c074f2aa34f75992aa71f2086fd49
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N40f30ab8d7ed4134a421cc0689d3ee0b
17 schema:citation sg:pub.10.1007/bf00253962
18 sg:pub.10.1007/bf00256691
19 sg:pub.10.1007/bf00292865
20 sg:pub.10.1023/a:1016410817898
21 https://app.dimensions.ai/details/publication/pub.1076981818
22 https://app.dimensions.ai/details/publication/pub.1078803298
23 https://app.dimensions.ai/details/publication/pub.1079490924
24 https://app.dimensions.ai/details/publication/pub.1079799337
25 https://app.dimensions.ai/details/publication/pub.1079909315
26 https://app.dimensions.ai/details/publication/pub.1079921497
27 https://app.dimensions.ai/details/publication/pub.1081549835
28 https://app.dimensions.ai/details/publication/pub.1081679216
29 https://app.dimensions.ai/details/publication/pub.1081779465
30 https://app.dimensions.ai/details/publication/pub.1081888390
31 https://app.dimensions.ai/details/publication/pub.1081992384
32 https://app.dimensions.ai/details/publication/pub.1082152911
33 https://app.dimensions.ai/details/publication/pub.1082240687
34 https://doi.org/10.1002/1097-0142(197711)40:5+<2660::aid-cncr2820400940>3.0.co;2-m
35 https://doi.org/10.1016/0277-5379(87)90053-8
36 https://doi.org/10.1111/j.2042-7158.1986.tb04552.x
37 schema:datePublished 1988-03
38 schema:datePublishedReg 1988-03-01
39 schema:description The effect of delayed uridine administration on the in vitro growth inhibitory effects of 5-fluorouracil (5FU) and on the in vivo antitumour activity and toxicity was studied. In vitro growth inhibition of the human intestinal cell lines WiDr and Intestine 407 by 3 microM 5FU could be reversed by 1.0 mM uridine; the effect was more pronounced with WiDr cells. At 0.1 mM uridine an intermediate effect was observed. Inhibition of colony formation in both cell lines could also be reversed by delayed administration of uridine at 0.1 and 1 mM. Incorporation of 5FU into RNA of WiDr cells did not proceed after addition of uridine, in contrast to Intestine 407 cells. In these cells only a partial inhibition was observed. In vivo we studied the effect of uridine on two colon carcinoma tumour lines, the 5FU sensitive Colon 38 and the relatively resistant Colon 26. 5FU was administered i.p. in a weekly schedule. With Colon 26 delayed administration of uridine (3500 mg kg-1) at 2 and 20 h after 5FU enabled us to increase the 5FU dose from 100 to 250 300mg kg-1. The combination of high-dose 5FU and uridine resulted both in a superior antitumour effect and an increase in life span. In the 5FU sensitive Colon 38 we determined whether the sensitivity to 5FU was affected by uridine. Mice were treated at the non-lethal dose of 100 mg kg-1 which inhibited tumour growth almost completely. Delayed administration of uridine did not significantly affect the antitumour effect. In non-tumour bearing mice we studied the time course of the reversal of the haematological toxicity of 5FU. The effective dose of 100 mg kg-1 induced a significant decrease in leukocytes; in combination with delayed uridine the leukopenia was less severe and recovered more rapidly. 5FU also induced a decrease in haematocrit, which could be prevented by delayed administration of uridine. In conclusion, in cell culture the reversal of 5FU cytotoxicity could be achieved at a low concentration of 0.1 mM uridine, the extent of the reversal might be related to the 5FU incorporation into RNA. In vivo the relatively resistant tumour Colon 26 could be treated with a higher dose of 5FU in the presence of uridine. The sensitivity to 5FU of the sensitive Colon 38 was not affected by delayed administration of uridine, while the haematological toxicity of 5FU was less. So, delayed administration of uridine after 5FU resulted in an improved therapeutic effect in both a relatively resistant and sensitive tumour.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree true
43 schema:isPartOf N4047bb2b27464dbf954502d440147f0f
44 N64cc2daea877459db88f2fd513bf446c
45 sg:journal.1017082
46 schema:name In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil
47 schema:pagination 259
48 schema:productId N5bad411c423145ba860139a29a76b737
49 Na9f23dd3388a4366bcbd006540381c67
50 Nab54ee486a3d43ea80808e25df9f7621
51 Nb6ff87d9cc334fb8b8312f06bb0bcfb4
52 Nf45dc2aef8c64ac5ba08aaa978e77209
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044394514
54 https://doi.org/10.1038/bjc.1988.56
55 schema:sdDatePublished 2019-04-11T12:12
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher Nef9c72831de74b0994f025b4166ef9a0
58 schema:url https://www.nature.com/articles/bjc198856
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N0b32b25d25f946ba875f3502bf0d71d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Fluorouracil
64 rdf:type schema:DefinedTerm
65 N10d2fdb3a6364e33b44dfd0b5d738df5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Animals
67 rdf:type schema:DefinedTerm
68 N1c6558e1d718484fa531c59a586c77c4 rdf:first sg:person.0717716531.20
69 rdf:rest N9a0fa0adbaef4f1b8ac2a5bf15c8689e
70 N2a914b0340514f6ea8dd1b57c24263f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Mice, Inbred BALB C
72 rdf:type schema:DefinedTerm
73 N3d2f34173cb54825aef2c5667559637b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Colonic Neoplasms
75 rdf:type schema:DefinedTerm
76 N4047bb2b27464dbf954502d440147f0f schema:issueNumber 3
77 rdf:type schema:PublicationIssue
78 N40f30ab8d7ed4134a421cc0689d3ee0b rdf:first sg:person.01255301342.17
79 rdf:rest N1c6558e1d718484fa531c59a586c77c4
80 N476fd41702144691b942da7058b8a729 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Tumor Cells, Cultured
82 rdf:type schema:DefinedTerm
83 N4811b0c0632d409f95ae6b57dd297341 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Female
85 rdf:type schema:DefinedTerm
86 N4a0ef22bd3fe4966b4aaff7db47c2f63 rdf:first sg:person.01031265312.27
87 rdf:rest N4cc28104a45c4d0595a07b53fbc3a4c3
88 N4cc28104a45c4d0595a07b53fbc3a4c3 rdf:first sg:person.013437631522.70
89 rdf:rest rdf:nil
90 N57e8516c7fdc488e9bb611fad2c28b00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Mice, Inbred C57BL
92 rdf:type schema:DefinedTerm
93 N5bad411c423145ba860139a29a76b737 schema:name dimensions_id
94 schema:value pub.1044394514
95 rdf:type schema:PropertyValue
96 N6152a3b450da4bf98d30b297a8518678 rdf:first sg:person.0655351752.04
97 rdf:rest N76d1d3f74bb6474ab5adffa4a7a9cdf6
98 N64cc2daea877459db88f2fd513bf446c schema:volumeNumber 57
99 rdf:type schema:PublicationVolume
100 N6ac99fe6f29d41aa84a867e3b9401016 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Bone Marrow
102 rdf:type schema:DefinedTerm
103 N76d1d3f74bb6474ab5adffa4a7a9cdf6 rdf:first sg:person.01222564175.18
104 rdf:rest N4a0ef22bd3fe4966b4aaff7db47c2f63
105 N81366d96ea184bc4971675edd27b7969 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Humans
107 rdf:type schema:DefinedTerm
108 N8ea1d51762fe4034a643dbd868a66152 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Drug Interactions
110 rdf:type schema:DefinedTerm
111 N9a0fa0adbaef4f1b8ac2a5bf15c8689e rdf:first sg:person.01217753643.01
112 rdf:rest Nbcd4234bd0764cb79e850506faed89a7
113 Na9f23dd3388a4366bcbd006540381c67 schema:name readcube_id
114 schema:value d377dd4f8106121fea2102b662251d3f8d39f6ab492bafcdec81e95ffb541213
115 rdf:type schema:PropertyValue
116 Nab54ee486a3d43ea80808e25df9f7621 schema:name doi
117 schema:value 10.1038/bjc.1988.56
118 rdf:type schema:PropertyValue
119 Naca72129c7d5481b97ceaeafa5b1039f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Uridine
121 rdf:type schema:DefinedTerm
122 Nb6ff87d9cc334fb8b8312f06bb0bcfb4 schema:name nlm_unique_id
123 schema:value 0370635
124 rdf:type schema:PropertyValue
125 Nbbe5161fbcfb4525b2b5b270f9dce0a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Intestinal Neoplasms
127 rdf:type schema:DefinedTerm
128 Nbcd4234bd0764cb79e850506faed89a7 rdf:first sg:person.01072777672.33
129 rdf:rest N6152a3b450da4bf98d30b297a8518678
130 Nef9c72831de74b0994f025b4166ef9a0 schema:name Springer Nature - SN SciGraph project
131 rdf:type schema:Organization
132 Nf45dc2aef8c64ac5ba08aaa978e77209 schema:name pubmed_id
133 schema:value 3355763
134 rdf:type schema:PropertyValue
135 Nf98c074f2aa34f75992aa71f2086fd49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Mice
137 rdf:type schema:DefinedTerm
138 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
139 schema:name Medical and Health Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
142 schema:name Oncology and Carcinogenesis
143 rdf:type schema:DefinedTerm
144 sg:journal.1017082 schema:issn 0007-0920
145 1532-1827
146 schema:name British Journal of Cancer
147 rdf:type schema:Periodical
148 sg:person.01031265312.27 schema:familyName Nadal
149 schema:givenName J C
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031265312.27
151 rdf:type schema:Person
152 sg:person.01072777672.33 schema:familyName van Groeningen
153 schema:givenName C J
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072777672.33
155 rdf:type schema:Person
156 sg:person.01217753643.01 schema:familyName Laurensse
157 schema:givenName E
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217753643.01
159 rdf:type schema:Person
160 sg:person.01222564175.18 schema:familyName Leyva
161 schema:givenName A
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222564175.18
163 rdf:type schema:Person
164 sg:person.01255301342.17 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
165 schema:familyName Peters
166 schema:givenName G J
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255301342.17
168 rdf:type schema:Person
169 sg:person.013437631522.70 schema:familyName Pinedo
170 schema:givenName H M
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013437631522.70
172 rdf:type schema:Person
173 sg:person.0655351752.04 schema:familyName Lankelma
174 schema:givenName J
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655351752.04
176 rdf:type schema:Person
177 sg:person.0717716531.20 schema:familyName van Dijk
178 schema:givenName J
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717716531.20
180 rdf:type schema:Person
181 sg:pub.10.1007/bf00253962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046577841
182 https://doi.org/10.1007/bf00253962
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/bf00256691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021909500
185 https://doi.org/10.1007/bf00256691
186 rdf:type schema:CreativeWork
187 sg:pub.10.1007/bf00292865 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035577687
188 https://doi.org/10.1007/bf00292865
189 rdf:type schema:CreativeWork
190 sg:pub.10.1023/a:1016410817898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049087466
191 https://doi.org/10.1023/a:1016410817898
192 rdf:type schema:CreativeWork
193 https://app.dimensions.ai/details/publication/pub.1076981818 schema:CreativeWork
194 https://app.dimensions.ai/details/publication/pub.1078803298 schema:CreativeWork
195 https://app.dimensions.ai/details/publication/pub.1079490924 schema:CreativeWork
196 https://app.dimensions.ai/details/publication/pub.1079799337 schema:CreativeWork
197 https://app.dimensions.ai/details/publication/pub.1079909315 schema:CreativeWork
198 https://app.dimensions.ai/details/publication/pub.1079921497 schema:CreativeWork
199 https://app.dimensions.ai/details/publication/pub.1081549835 schema:CreativeWork
200 https://app.dimensions.ai/details/publication/pub.1081679216 schema:CreativeWork
201 https://app.dimensions.ai/details/publication/pub.1081779465 schema:CreativeWork
202 https://app.dimensions.ai/details/publication/pub.1081888390 schema:CreativeWork
203 https://app.dimensions.ai/details/publication/pub.1081992384 schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1082152911 schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1082240687 schema:CreativeWork
206 https://doi.org/10.1002/1097-0142(197711)40:5+<2660::aid-cncr2820400940>3.0.co;2-m schema:sameAs https://app.dimensions.ai/details/publication/pub.1012307934
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/0277-5379(87)90053-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036522081
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1111/j.2042-7158.1986.tb04552.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028831366
211 rdf:type schema:CreativeWork
212 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
213 schema:name Department of Oncology, Free University Hospital, Amsterdam, The Netherlands.
214 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...